Clinical Study
CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients
Table 3
Multivariate analysis of risk factors for aGvHD (grade > I).
| Variable | Coefficient | value | Odds ratio | 95% CI |
| CMV infection/reactivation event within 1 year post HSCT | 0.5473 | 0.1362 | 1.7286 | 0.8415 to 3.5509 | CMV IgG in donor serum | 0.0290 | 0.9411 | 1.0295 | 0.4762 to 2.2254 | Donor-recipient HLA mismatch | 0.8591 | 0.0421 | 2.3611 | 1.0310 to 5.4072 | Unrelated donor | 0.9520 | 0.0355 | 2.5909 | 1.0669 to 6.2921 | BM as a source of cells | ā0.6177 | 0.3090 | 0.5392 | 0.1640 to 1.7723 |
|
|